Avi Assidon, MD (@AviFSU) profile picture

@nyulangone | @FloridaState | @FSUCoM | @stanfordhealth | @typeonevc Advisor | Regenerative Med @CellStanford | @lluhealth | @beondeck Longevity Fellow

Los Angeles, CA
Joined September 2010
Photo by Avi Assidon, MD (@AviFSU)Photo by Avi Assidon, MD (@AviFSU)Photo by Avi Assidon, MD (@AviFSU)Photo by Avi Assidon, MD (@AviFSU)Photo by Avi Assidon, MD (@AviFSU)Photo by Avi Assidon, MD (@AviFSU)Photo by Avi Assidon, MD (@AviFSU)Photo by Avi Assidon, MD (@AviFSU)Photo by Avi Assidon, MD (@AviFSU)
🤰 Are GLP-1 receptor agonists a danger if taken around the time of conception? A new systematic review and meta-analysis pools the largest reproductive-safety dataset to date: 6 studies, 286,599 women, 43,577 exposed to GLP-1 RAs. 📊 Major congenital malformations: RR 1.02 (95% CI 0.96–1.08). No signal. Other outcomes were also non-significant: ⬇️ Small for Gestational Age: RR 0.71 (0.39–1.27) ➡️ Preterm birth: RR 1.09 (0.80–1.49) ➡️ Large for Gestational Age: RR 2.31 (0.56–9.44) ➡️ Stillbirth: RR 1.16 (0.24–5.69) ⚠️ The LGA and stillbirth confidence intervals are extremely wide. This is a limitation of the available data, not a reassurance. 🔑 This is reassuring but still limited data we have for inadvertent periconceptional GLP-1 RA exposure. It is not a green light for intentional use during pregnancy. The recommendation remains to discontinue GLP-1 RAs at least 2 months before planned conception. But for the patient who discovers their pregnant while on semaglutide or tirzepatide, this data should ease anxiety. doi.org/10.1530/ec-26-0280
1
37
6
103
21,085
Avi Assidon, MD retweeted
Yale Urology is seeking a PGY-3 resident to join our program starting July 1, 2026. We offer exceptional surgical training, high-volume operative experience, all subspecialties, diverse practice settings, research opportunities, and career mentorship. 🧵1 of 2
1
26
4
55
31,283
Avi Assidon, MD retweeted
Built a free biologics COGS estimator covering mAbs, recombinant proteins, ADCs, and C&GT, with GMP/Tox/RG options. For founders, investors, and BD folks who need a defensible cost figure for pitching/evaluating. Feedback welcome; still iterating! biologics.tools
6
6
2
63
20,553
Avi Assidon, MD retweeted
We have had a vacancy come up in our residency program, and will have a URO-3 position available for the upcoming academic year beginning around July 1. Please reach out, or forward your CV to [email protected] if you would like to learn more!
2
18
2
40
32,844
Avi Assidon, MD retweeted
Urologists!! What is the proper way to stand?? I developed C5-6 radiculopathy from 30yrs poor posture. Look & Learn “How to Stand”
8
9
2
82
12,094
Avi Assidon, MD retweeted
Last week to apply for the ACS Health Policy Scholarships! Had the privilege of attending last year and spending a week at Brandeis learning from and with leading surgeons in the health policy space. Highly recommend! facs.org/for-medical-profess…
4
10
1,653
Avi Assidon, MD retweeted
👩‍⚕️👨‍⚕️ Urologists 🌍— we need your voice! 📢 From RIRS to PCNL to TURP and HoLEP: what anesthesia do you prefer, and why? Contribute here: redcap.urmc.rochester.edu/re… @FUTURE_EndoSoc @Endo_Society @young_endosoc @Uroweb @BAUSurology @CanUrolAssoc @SWIUorg @EthioUrology
4
12
1
27
3,880
Avi Assidon, MD retweeted
Last day to apply !!
It’s that time of the year .. apply to our incredible research opportunity to work with world leaders in GU oncology 🔥Exciting projects in RCC AI, AI pathology, @arteraAI @valarlabs @DropletBiosci @NateraGenetics among many others ‼️travel to all major GU conferences including EAU 💥 1:1 mentorship reach out to our @CanDAydogdu @gabrielamdd for more info #UrologyMatch2026 @UrologyMatch @Uro_Res @UroResidency
1
6
18
5,741
I'll be there advocating for the removal of the boxed labeling on vaginal estrogen. Sign the petition! Watch us on July 17 letstalkmenopause.org/unboxi…
This Post is from an account that no longer exists. Learn more
5
24
2
145
19,124
Avi Assidon, MD retweeted
Arc is hiring a Chief Scientific Officer! Come work with at what I think is the most dynamic and ambitious biology research organization in the world, partnering with @pdhsu, @SKonermann, @davey_burke, Arc's extraordinary faculty, and many more. We want to build the world's first virtual cell + use it to develop cures to complex diseases like Alzheimer's. More details below.
22
66
7
815
279,340
Hospitals Acquired By Private Equity Firms: Increased Postoperative Mortality For Common Inpatient Surgeries @DiazAdrian10 @jdimick1 @Health_Affairs @UMichCHOP healthaffairs.org/doi/abs/10…
1
43
2
104
12,083
Avi Assidon, MD retweeted
Upcoming @AmerUrological residency grads: we have one uro onc/robotic surgery fellowship position open for July 2025 start. If interested, please let me know! 1000+ majors/year, amazing mentors, big whacks, small incisions, multi-d, clinical trials, and everything in between☺️
2
10
2
28
9,389
Avi Assidon, MD retweeted
Gotta be honest. The @realDonaldTrump EO on healthcare and in particular, drug pricing could save hundreds of billions. Here is how: 1. Divorce formularies from PBMs. Require them to come from independent organizations with no economic incentive from the formulary Make them about wellness, not pay for play like a grocery store endcap. This ends rebates and allows for net pricing. It also allows for better care and wellness. 2. Require PBMs to provide ALL claims data to employers, states and manufacturers. The manufacturers need this to provide better results. It’s insane they don’t have this data to analyze and improve patient results. Plus they current pay 5 to 10 pct of the retail price to get that data so they can do just that. Make it so it’s required and they can save 10pct of RETAIL pricing , which they can use to lower pricing. This also stops the 340b double dipping problem. 3. Remove the specialty tier and the requirement to buy from any specified pharmacy. There is nothing special about specialty drugs. They call them special to jack up the price. And of course have them divest any that they do. 4. Require that all pharmacies get fully reimbursed for brand drugs and get rid of the Generic Cost Ratio which allows distributors to jack up pricing on generics with the threat of chargebacks and more.. We need independent pharmacies to thrive 5. Remove confidentiality clauses. They prevent companies from talking to manufacturers. It’s insane that your company can’t talk to a GLP1 manufacturer (as an example) to help you put together a wellness plan and get you a better price 6. Stop biosimilar substitution calls. PBMs know that they need to find new sources of margin. They do it by white labeling their own biosimilar versions. That’s fine. But because that’s where all the margin is, they will put a low cost biosim on the formulary, and when they get a script for the lower cost option, they will have someone call the prescribing doctor to switch to their more expensive version they make more money on. And because employers and manufacturers don’t get their data. They never know Put me in coach ! I’m here to help.
1,908
2,097
347
20,956
2,836,569
Avi Assidon, MD retweeted
81 new cases of measles in Texas this past week. 481 cases have been identified since late January. 56 of the patients have been hospitalized. 1 child has died. Vaccinate your children. dshs.texas.gov/news-alerts/m…
61
1
145
3,685
143
1,196
65
31,616
1,909,649
Your Match Day reminder that square knots look the same at hospitals of every ranking, and matching *somewhere* is what matters. The grass is not always greener at your ‘top’ programs, and in the end, both your potential and the basic principles of surgery are still the same.
9
91
12
599
49,557
There is no algorithm that can replace the instincts of an experienced physician when faced with a patient in need. When the doctor who saw this patient in the Emergency Room examined her, spoke with her, and decided to admit her, I know that he did so because he knew best how to keep her safe. I am grateful. I am disturbed that her insurance company questioned that judgement and presumes to know better than the doctor in front of her. The following statement in the denial letter says so much about the current state of healthcare: “When a doctor or facility treats a patient above the recommended level of care, we cannot cover it.” This does not pass the sister test. I’ll take the best judgement of the doctor who was physically present at the bedside of a frightened patient over an insurance company’s algorithm every time. And I refuse to accept that this is the best we as a society can do.
83
203
33
925
311,385
Avi Assidon, MD retweeted
Another unvaccinated person dies from measles, a fully preventable disease, only the second person (1st was a 6 year old child, Feb 26th) to die from measles in the US since 2015 washingtonpost.com/health/20… (this is a correction of prior post that was deleted)
5
58
4
148
20,580
Avi Assidon, MD retweeted
In @AJR_Radiology, we found that private equity acquisitions of radiology practices surged from 2013-2023, now employing 12% of U.S. radiologists. In states like Nevada & Arizona, nearly half of radiologists work for PE firms. doi.org/10.2214/AJR.25.32738 @ysingh_phd @CAHPR_BrownSPH
3
2
15
1,734